Generation Bio raises $100M for ‘druglike’ gene therapy – FierceBiotech
FierceBiotech |
Generation Bio raises $100M for ‘druglike’ gene therapy
FierceBiotech Gene therapy startup Generation Bio has lost no time raising the resources it needs to take its programs forward into the clinic, closing a $100 million second-round financing just over a month after its $25 million Series A. The Atlas Venture-backed … Fresh Off $25M Raise, Generation Adds $100M For Next-Gen Gene TherapyXconomy Hauling in a $100M mega-round, gene therapy startup Generation Bio builds alternative to potentially risky viral vectorsEndpoints News Redosable Gene–Therapy Developer Generation Bio Wins $100M Series B FinancingGenetic Engineering & Biotechnology News Boston Business Journal –Business Wire (press release) all 7 news articles » |
|
Gilead’s Hunt And The Crispr Crapshoot (Podcast)
Seeking Alpha M&A in the pharma industry is often nothing more than a roll of the dice. CRISPR Therapeutics’ stock has shot up in the last two months with little or no obvious explanation. Could Gilead Sciences be lurking? That’s BioSci Capital Partners’ recent … |
TechCrunch |
All-star team of synthetic biologists raise $53 million for cancer therapy startup Senti
TechCrunch A who’s-who from the world of synthetic biological research have come together to launch Senti Biosciences with $53 million in funding from a slew of venture capital investors. Led by Tim Lu, a longtime researcher at the Massachusetts Institute of … |